- Diabetes
- May 14, 2026
- 9 MINS READ
📷 IMAGE PLACEHOLDER
Suggested alt text: Diabetes Medications Explained: Metformin, SGLT2 Inhibitors, GLP-1 Agonists, and Insulin — hero image for MCR Diabetes & Eye Care, Kannur
MCR Diabetes & Eye Care · Kannur, Kerala
+91 9497 222 722
Diabetes Medications Explained: Metformin, SGLT2 Inhibitors, GLP-1 Agonists, and Insulin
Diabetes medication has changed dramatically in the past decade. Where treatment was once limited to metformin, sulphonylureas, and insulin, today there are seven major drug classes — some with benefits that go far beyond blood sugar lowering, including protection of the heart and kidneys. Understanding what you are taking, why, and what alternatives exist is one of the most empowering things a person with diabetes can do. Our specialist diabetologist at MCR Diabetes & Eye Care, Kannur, walks you through every major class.
This guide is educational, not a replacement for individual medical advice. Medication choices are always personalised based on HbA1c, kidney function, heart history, weight, cost, and side effect tolerance. However, knowing the landscape helps you have informed conversations with your diabetologist. For a personalised medication review, book an appointment at MCR’s diabetology service.
The Seven Main Classes of Diabetes Medication
Class 1: Metformin (Biguanides)
Metformin has been the first-line medication for type 2 diabetes for over 60 years, and remains so for excellent reasons. It works primarily by reducing glucose production by the liver and improving insulin sensitivity in muscles.
How It Works
Metformin suppresses gluconeogenesis (glucose production) in the liver and modestly improves how cells respond to insulin. Unlike many medications, it does not cause low blood sugar when used alone.
Benefits
- Lowers HbA1c by 1.0-1.5%
- Does not cause weight gain (often modest weight loss)
- Does not cause hypoglycaemia alone
- Very low cost (₹50-200 per month in India)
- May have modest cardiovascular protection
Common Side Effects
- Gastrointestinal: nausea, diarrhoea, abdominal cramps (usually settles in 2-4 weeks)
- Metallic taste in mouth
- Vitamin B12 deficiency with long-term use (annual B12 check recommended)
Tips to Minimise Side Effects
- Start with low dose (500 mg once daily) and increase gradually
- Take with food
- Use extended-release (XR) form if regular form is poorly tolerated
Key fact: Modern diabetes medications protect more than just blood sugar. SGLT2 inhibitors reduce heart failure hospitalisation by 27-35% and slow kidney disease by 30-40%. GLP-1 agonists reduce cardiovascular events and produce 5-20% weight loss.
Class 2: SGLT2 Inhibitors
SGLT2 inhibitors are among the most exciting recent additions to diabetes care. They work in a completely novel way — by causing the kidneys to excrete excess glucose in the urine.
Examples
Common names in India: empagliflozin (Jardiance), dapagliflozin (Forxiga), canagliflozin (Invokana).
Benefits Beyond Blood Sugar
Multiple major clinical trials have shown SGLT2 inhibitors reduce:
- Risk of heart failure hospitalisation by 27-35%
- Progression of chronic kidney disease by 30-40%
- Cardiovascular death in high-risk patients
- Body weight by 2-4 kg on average
- Blood pressure modestly
Common Side Effects
- Genital fungal infections (4-12% of patients, more common in women)
- Urinary tract infections (modest increase)
- Increased urination, especially initially
- Rare: diabetic ketoacidosis (especially during illness or surgery)
Cost
Approximately ₹600-2,000 per month for branded versions; generics are increasingly available.
Class 3: GLP-1 Receptor Agonists
GLP-1 receptor agonists are injectable (and now some oral) medications that mimic the natural gut hormone GLP-1. They are extremely effective at lowering HbA1c, supporting weight loss, and reducing cardiovascular events.
Examples
Common names: liraglutide (Victoza), semaglutide (Ozempic injection, Rybelsus tablet), dulaglutide (Trulicity), tirzepatide (Mounjaro — actually a dual GIP/GLP-1).
Benefits
- Lowers HbA1c by 1.0-2.0%
- Significant weight loss: 4-15 kg depending on agent
- Cardiovascular protection in proven outcomes trials
- Some kidney protection
- No risk of hypoglycaemia alone
Common Side Effects
- Nausea, especially when starting (settles in 2-4 weeks)
- Constipation or diarrhoea
- Gallbladder issues (uncommon but possible)
- Injection site reactions for injectable forms
Cost
Branded GLP-1 agonists remain expensive in India: ₹3,000-12,000 per month depending on agent. Generic semaglutide is increasingly available at lower cost.
⚠ Important: Never stop diabetes medications on your own — sudden discontinuation can cause severe hyperglycaemia or ketoacidosis. Side effects, costs, or concerns should always be discussed with your diabetologist, who can switch or adjust your regimen safely.
Class 4: DPP-4 Inhibitors
DPP-4 inhibitors are oral medications that prolong the action of natural GLP-1 and similar hormones. They are weight-neutral, very well tolerated, and inexpensive.
Examples
Common names: sitagliptin (Januvia), vildagliptin (Galvus), saxagliptin (Onglyza), linagliptin (Tradjenta), teneligliptin (Tenelibest, Zita).
Benefits
- Lowers HbA1c by 0.5-0.9%
- Weight-neutral
- Very low risk of hypoglycaemia alone
- Excellent safety profile, even in elderly
- Generally well tolerated
Cost
Generic teneligliptin is widely available in India at ₹200-400 per month, making this class accessible to most patients.
Class 5: Sulphonylureas
Older oral medications that stimulate the pancreas to release more insulin. Effective but with limitations.
Examples
Glimepiride, glipizide, gliclazide are most common in India.
Benefits
- Lowers HbA1c by 1.0-1.5%
- Very low cost (₹50-150 per month)
- Long clinical experience
Disadvantages
- Hypoglycaemia risk (especially with skipped meals)
- Weight gain of 1-3 kg
- Pancreatic exhaustion over years
- Newer agents generally preferred when affordable
Class 6: Pioglitazone (Thiazolidinediones)
Pioglitazone improves insulin sensitivity, particularly in fat and muscle tissue. It is effective and inexpensive but has specific concerns.
Benefits
- Lowers HbA1c by 0.8-1.2%
- Improves fatty liver disease
- May reduce cardiovascular events in some patients
- Very low cost
Concerns
- Fluid retention and weight gain
- Increased fracture risk in postmenopausal women
- Bladder cancer concerns (small, possibly disputed)
- Not for use in heart failure
Class 7: Insulin
Insulin is the most powerful glucose-lowering medication. It is essential for type 1 diabetes and is used in type 2 diabetes when other agents are insufficient. Modern insulins are far better than older versions.
Types of Insulin
- Basal (long-acting): glargine (Lantus, Basalog), degludec (Tresiba), detemir (Levemir) — given once or twice daily
- Bolus (rapid-acting): aspart (NovoRapid), lispro (Humalog), glulisine (Apidra) — given with meals
- Premixed: combinations of basal and rapid (e.g. NovoMix 30, Humalog Mix) — given twice daily
- Older insulins: regular and NPH — still used but less ideal
Common Concerns
- Hypoglycaemia (low blood sugar)
- Weight gain
- Injection burden (now minimal with thin needles)
- Storage requirements
When Insulin Is Needed
Insulin is necessary for: all type 1 diabetes, type 2 diabetes with very high HbA1c (over 10%), pregnancy with diabetes, hospitalisation, severe infection, and type 2 diabetes that has not responded to multiple oral agents.
Get a Medication Review at MCR
Our diabetologist regularly reviews medication regimens to ensure they are effective, affordable, and protective. New medications may be appropriate for you.
Choosing the Right Medication: Personalised Decisions
Modern diabetes care moves beyond a “stepwise” approach toward individualised treatment. Key factors include:
- HbA1c level — higher levels often need multiple drugs from the start
- Heart disease history — favours SGLT2 inhibitors and GLP-1 agonists
- Kidney disease — favours SGLT2 inhibitors and certain GLP-1 agonists
- Weight — overweight patients benefit from GLP-1 agonists or SGLT2 inhibitors
- Heart failure — strongly favours SGLT2 inhibitors
- Cost — metformin, sulphonylureas, generic DPP-4 inhibitors are most affordable
- Hypoglycaemia concern — avoid sulphonylureas if possible
- Side effect history — past intolerance of any class
Diabetes Medications at a Glance
| Goal | Recommended Class |
|---|---|
| Standard first-line | Metformin |
| Heart disease history | SGLT2 inhibitor or GLP-1 agonist |
| Heart failure | SGLT2 inhibitor |
| Kidney disease | SGLT2 inhibitor |
| Weight loss needed | GLP-1 agonist or SGLT2 inhibitor |
| Limited budget | Metformin + sulphonylurea or DPP-4 generic |
| Very high HbA1c (>10%) | Insulin initially |
| Avoid hypoglycaemia | Metformin, SGLT2, GLP-1, DPP-4 |
Frequently Asked Questions
Below are the questions our patients ask most often. If you have additional questions, our specialist team at MCR Diabetes & Eye Care, Kannur, is always available to help.
Why am I on more than one diabetes medication?
Multiple medications often work better than a single high-dose drug, with fewer side effects. Different classes target different mechanisms — combining them gives broader and stronger blood sugar control while protecting against complications.
Will I need insulin eventually?
Not necessarily. Many people manage type 2 diabetes with oral medications and lifestyle for decades. Insulin is needed when other agents are insufficient, but modern medications like GLP-1 agonists delay or prevent insulin requirement for many patients.
What about metformin side effects?
GI side effects (nausea, diarrhoea) affect 10-20% of users but usually settle within 2-4 weeks. Strategies: start low and increase gradually, take with food, use extended-release form, divide doses. If still intolerant, other classes are excellent alternatives.
Are diabetes medications safe long-term?
Yes, when prescribed appropriately. Metformin has 60+ years of safety data. SGLT2 inhibitors and GLP-1 agonists have extensive trial and post-marketing safety data. Insulin is the most studied medication in medicine. Side effects, when they occur, are usually manageable.
Can I take generic versions?
Yes, generics of well-established medications (metformin, sulphonylureas, DPP-4 inhibitors, some SGLT2 inhibitors) are widely available in India and equally effective. Quality varies by manufacturer; reputable brands are recommended.
Do I need to take medication if I have controlled diabetes?
If you have achieved remission (HbA1c below 6.5% sustained without medication), you may not need medication. However, most people with diabetes benefit from continued medication for cardiovascular and kidney protection, even when sugars are well controlled.
How often should my medications be reviewed?
At least annually, more often if not at target or if you have new health issues. Many patients are still on older regimens that could be improved with newer, more protective medications.
Final Takeaway: Medication Is a Tool, Not a Failure
Some patients view starting medication as a personal failure. It is not. Type 2 diabetes is a progressive disease in most people, and medications are powerful tools that prevent complications, extend life, and improve quality of life. The right medication, taken consistently, alongside the right lifestyle, gives you the best possible outcome.
At MCR Diabetes & Eye Care, Kannur, we regularly review our patients’ medication regimens to ensure they are on the most appropriate, effective, and affordable combinations. Many patients are still on older regimens that could be improved. If you have not had a medication review in the past year — or if you are struggling with side effects, costs, or control — book a consultation today.
You May Also Find Helpful
- Type 2 Diabetes Symptoms: Early Warning Signs
- Diabetes Reversal and Remission
- CGM in India: Complete Guide
- HbA1c Test: Normal Range and Targets
Tags: Diabetes Medications · Metformin · SGLT2 Inhibitors · GLP-1 Agonists · Insulin · Diabetes Treatment